Sean N. Tucker's most recent trade in Vaxart Inc was a trade of 3,913 Common Stock done at an average price of $0.4 . Disclosure was reported to the exchange on March 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.42 per share. | 28 Mar 2025 | 3,913 | 740,490 (1%) | 0% | 0.4 | 1,648 | Common Stock |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2025 | 610,000 | 610,000 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2025 | 406,000 | 744,403 (1%) | 0% | 0 | Common Stock | |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.57 per share. | 18 Mar 2025 | 8,050 | 338,403 (0%) | 0% | 0.6 | 4,590 | Common Stock |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.68 per share. | 02 Feb 2025 | 9,242 | 346,453 (0%) | 0% | 0.7 | 6,283 | Common Stock |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. | 28 Mar 2024 | 3,902 | 355,695 (0%) | 0% | 1.3 | 5,073 | Common Stock |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2023 | 410,000 | 410,000 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2023 | 90,000 | 420,122 (0%) | 0% | 0 | Common Stock | |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.71 per share. | 28 Mar 2023 | 34,288 | 339,342 (0%) | 0% | 0.7 | 24,344 | Common Stock |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 28 Mar 2023 | 9,220 | 330,122 (0%) | 0% | 1.2 | 11,064 | Common Stock |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.75 per share. | 28 Mar 2023 | 3,683 | 373,630 (0%) | 0% | 0.7 | 2,762 | Common Stock |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 410,000 | 410,000 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 205,000 | 205,000 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 90,000 | 316,788 (0%) | 0% | 0 | Common Stock | |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 54,157 | 226,788 (0%) | 0% | 0 | Common Stock | |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 45,000 | 172,631 (0%) | 0% | 0 | Common Stock | |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2022 | 40,000 | 84,061 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.77 per share. | 22 Apr 2022 | 40,000 | 127,631 (0%) | 0% | 0.8 | 30,800 | Common Stock |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 262,500 | 262,500 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 43,750 | 87,631 (0%) | 0% | 0 | Common Stock | |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.20 per share. | 10 Aug 2021 | 5,828 | 51,465 (0%) | 0% | 10.2 | 59,446 | Common Stock |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.20 per share. | 10 Aug 2021 | 4,172 | 43,881 (0%) | 0% | 10.2 | 42,554 | Common Stock |
| Vaxart Inc | Sean N. Tucker | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Sean N. Tucker | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 1,006 | 0 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Sean N. Tucker | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.49 per share. | 16 Mar 2021 | 1,006 | 48,053 (0%) | 0% | 6.5 | 6,529 | Common Stock |